医学
前列腺癌
骨质疏松症
雄激素剥夺疗法
健骨
疾病
癌症
前列腺
肿瘤科
物理疗法
重症监护医学
内科学
骨矿物
作者
Hsien-Ho Lin,Ravi B. Parikh
标识
DOI:10.1016/j.euf.2023.04.005
摘要
Prostate cancer survivors face an elevated lifetime risk of fracture due to factors that include older age, bony metastases, and use of androgen deprivation therapy in the curative setting, which increases the risk of osteoporosis and fracture. Management of bone health is critical to prevent fracture and other bone-related complications; however, routine bone health screening is seldom performed and is inadequate. In this mini-review, we discuss optimal bone health management for prostate cancer survivors who have received curative-intent therapy. We also discuss areas for future improvement. PATIENT SUMMARY: This mini-review discusses the importance of bone health for prostate cancer survivors who had nonmetastatic disease, steps to improve bone health, and areas for improvement.
科研通智能强力驱动
Strongly Powered by AbleSci AI